Drug intelligence / Profile preview

PC-104

Development stage
Preclinical
Lead developer
Exeltis USA Dermatology
Modality
Small Molecules
Administration
Topical
01

Overview

**PC-104** is a synthetic pseudoceramide, chemically identified as hydroxypropyl bispalmitamide MEA, designed to mimic the barrier-supporting functions of endogenous stratum-corneum ceramides. It is used topically as a skin-conditioning and barrier-restoring ingredient that increases skin hydration and reduces transepidermal water loss. In a four-week clinical study, PC-104 was administered within a proprietary topical cream also containing palmitamide MEA, glycyrrhetinic acid, and grape seed extract; the combination improved signs and symptoms of mild-to-moderate atopic dermatitis and other pruritic dermatoses. PC-104 originated from Amorepacific pseudoceramide research and was subsequently evaluated in an Exeltis-supported therapeutic cream study.

Other names
Ceramide PC 104Ceramide PC-104hydroxypropyl bispalmitamide MEAhydroxypropyl bispalmitamide monoethanolamide

Beyond the preview

Go deeper on PC-104.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PC-104.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call